TrialLancet (London, England)2013

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Joy N Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.